230 related articles for article (PubMed ID: 18337727)
1. ARLTS1 germline variants and the risk for breast, prostate, and colorectal cancer.
Siltanen S; Syrjäkoski K; Fagerholm R; Ikonen T; Lipman P; Mallott J; Holli K; Tammela TL; Järvinen HJ; Mecklin JP; Aittomäki K; Blomqvist C; Bailey-Wilson JE; Nevanlinna H; Aaltonen LA; Schleutker J; Vahteristo P
Eur J Hum Genet; 2008 Aug; 16(8):983-91. PubMed ID: 18337727
[TBL] [Abstract][Full Text] [Related]
2. ARLTS1 variants and risk of colorectal cancer.
Frank B; Hemminki K; Brenner H; Hoffmeister M; Chang-Claude J; Burwinkel B
Cancer Lett; 2006 Dec; 244(2):172-5. PubMed ID: 16488076
[TBL] [Abstract][Full Text] [Related]
3. Association of the ARLTS1 Cys148Arg variant with familial breast cancer risk.
Frank B; Hemminki K; Meindl A; Wappenschmidt B; Klaes R; Schmutzler RK; Untch M; Bugert P; Bartram CR; Burwinkel B
Int J Cancer; 2006 May; 118(10):2505-8. PubMed ID: 16353159
[TBL] [Abstract][Full Text] [Related]
4. Association of the ARLTS1 variants with familial ovarian cancer risk in China.
Yang XY; Yu H; Xi MR; Yang KX; Pan XL; Hu M; Peng ZL
Int J Gynecol Cancer; 2009 May; 19(4):585-90. PubMed ID: 19509554
[TBL] [Abstract][Full Text] [Related]
5. Contribution of ARLTS1 Cys148Arg (T442C) variant with prostate cancer risk and ARLTS1 function in prostate cancer cells.
Siltanen S; Wahlfors T; Schindler M; Saramäki OR; Mpindi JP; Latonen L; Vessella RL; Tammela TL; Kallioniemi O; Visakorpi T; Schleutker J
PLoS One; 2011; 6(10):e26595. PubMed ID: 22028916
[TBL] [Abstract][Full Text] [Related]
6. Association of the ARLTS1 Cys148Arg variant with sporadic and familial colorectal cancer.
Castellví-Bel S; Castells A; de Cid R; Muñoz J; Balaguer F; Gonzalo V; Ruiz-Ponte C; Andreu M; Llor X; Jover R; Bessa X; Xicola RM; Pons E; Alenda C; Payá A; Carracedo A; Piqué JM;
Carcinogenesis; 2007 Aug; 28(8):1687-91. PubMed ID: 17449901
[TBL] [Abstract][Full Text] [Related]
7. Familial cancer associated with a polymorphism in ARLTS1.
Calin GA; Trapasso F; Shimizu M; Dumitru CD; Yendamuri S; Godwin AK; Ferracin M; Bernardi G; Chatterjee D; Baldassarre G; Rattan S; Alder H; Mabuchi H; Shiraishi T; Hansen LL; Overgaard J; Herlea V; Mauro FR; Dighiero G; Movsas B; Rassenti L; Kipps T; Baffa R; Fusco A; Mori M; Russo G; Liu CG; Neuberg D; Bullrich F; Negrini M; Croce CM
N Engl J Med; 2005 Apr; 352(16):1667-76. PubMed ID: 15843669
[TBL] [Abstract][Full Text] [Related]
8. Cancer Familial Aggregation (CFA) and G446A polymorphism in ARLTS1 gene.
Masojć B; Mierzejewski M; Cybulski C; van de Wetering T; Debniak T; Górski B; Jaworowska E; Tarnowska C; Lenner M; Scott RJ; Lubiński J
Breast Cancer Res Treat; 2006 Sep; 99(1):59-62. PubMed ID: 16570116
[TBL] [Abstract][Full Text] [Related]
9. ARLTS1 variants and melanoma risk.
Frank B; Meyer P; Boettger MB; Hemminki K; Stapelmann H; Gast A; Schmitt C; Kumar R; Sergi C; Burwinkel B
Int J Cancer; 2006 Oct; 119(7):1736-7. PubMed ID: 16646072
[TBL] [Abstract][Full Text] [Related]
10. ARLTS1 and prostate cancer risk--analysis of expression and regulation.
Siltanen S; Fischer D; Rantapero T; Laitinen V; Mpindi JP; Kallioniemi O; Wahlfors T; Schleutker J
PLoS One; 2013; 8(8):e72040. PubMed ID: 23940804
[TBL] [Abstract][Full Text] [Related]
11. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
Jonsson BA; Bergh A; Stattin P; Emmanuelsson M; Grönberg H
Int J Cancer; 2002 Apr; 98(6):838-43. PubMed ID: 11948460
[TBL] [Abstract][Full Text] [Related]
12.
Jiang Y; Zhao CY; Cheng LC; Xu B; Lv HY
Hered Cancer Clin Pract; 2017; 15():8. PubMed ID: 28630657
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes.
Kote-Jarai Z; Mikropoulos C; Leongamornlert DA; Dadaev T; Tymrakiewicz M; Saunders EJ; Jones M; Jugurnauth-Little S; Govindasami K; Guy M; Hamdy FC; Donovan JL; Neal DE; Lane JA; Dearnaley D; Wilkinson RA; Sawyer EJ; Morgan A; Antoniou AC; Eeles RA;
Ann Oncol; 2015 Apr; 26(4):756-761. PubMed ID: 25595936
[TBL] [Abstract][Full Text] [Related]
14. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.
Gayther SA; de Foy KA; Harrington P; Pharoah P; Dunsmuir WD; Edwards SM; Gillett C; Ardern-Jones A; Dearnaley DP; Easton DF; Ford D; Shearer RJ; Kirby RS; Dowe AL; Kelly J; Stratton MR; Ponder BA; Barnes D; Eeles RA
Cancer Res; 2000 Aug; 60(16):4513-8. PubMed ID: 10969800
[TBL] [Abstract][Full Text] [Related]
15. ARLTS1, potential candidate gene in familial aggregation of hematological malignancies.
Hamadou WS; Besbes S; Mani R; Bourdon V; Ben Youssef Y; Achour B; Regaieg H; Eisinger F; Mari V; Gesta P; Dreyfus H; Bonadona V; Dugast C; Zattara H; Faivre L; Noguchi T; Khélif A; Sobol H; Soua Z
Bull Cancer; 2017 Feb; 104(2):123-127. PubMed ID: 27866680
[TBL] [Abstract][Full Text] [Related]
16. Association study of prostate cancer susceptibility variants with risks of invasive ovarian, breast, and colorectal cancer.
Song H; Koessler T; Ahmed S; Ramus SJ; Kjaer SK; Dicioccio RA; Wozniak E; Hogdall E; Whittemore AS; McGuire V; Ponder BA; Turnbull C; Hines S; Rahman N; ; Eeles RA; Easton DF; Gayther SA; Dunning AM; Pharoah PD
Cancer Res; 2008 Nov; 68(21):8837-42. PubMed ID: 18974127
[TBL] [Abstract][Full Text] [Related]
17. ARLTS1, MDM2 and RAD51 gene variations are associated with familial breast cancer.
Akisik E; Yazici H; Dalay N
Mol Biol Rep; 2011 Jan; 38(1):343-8. PubMed ID: 20358297
[TBL] [Abstract][Full Text] [Related]
18. Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer.
Petrocca F; Iliopoulos D; Qin HR; Nicoloso MS; Yendamuri S; Wojcik SE; Shimizu M; Di Leva G; Vecchione A; Trapasso F; Godwin AK; Negrini M; Calin GA; Croce CM
Cancer Res; 2006 Nov; 66(21):10287-91. PubMed ID: 17079447
[TBL] [Abstract][Full Text] [Related]
19. Familial transmission of prostate, breast and colorectal cancer in adoptees is related to cancer in biological but not in adoptive parents: a nationwide family study.
Zöller B; Li X; Sundquist J; Sundquist K
Eur J Cancer; 2014 Sep; 50(13):2319-27. PubMed ID: 24953336
[TBL] [Abstract][Full Text] [Related]
20. HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk.
Laitinen VH; Wahlfors T; Saaristo L; Rantapero T; Pelttari LM; Kilpivaara O; Laasanen SL; Kallioniemi A; Nevanlinna H; Aaltonen L; Vessella RL; Auvinen A; Visakorpi T; Tammela TL; Schleutker J
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):452-60. PubMed ID: 23292082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
